A recent study in PLOS Genetics shows that doxifluridine rescues aging-related alternative splicing issues and extends lifespan in C. elegans via bacterial metabolism. For instance, live bacteria metabolize the drug into active compounds that improve cellular functions, sparking interest in novel longevity therapies.